Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

NCT00046917 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: alvocidib
DRUG: irinotecan hydrochloride
DRUG: cisplatin

Sponsor

National Cancer Institute (NCI)